---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-097603"
form_type: "8-K"
ticker: "XLO"
cik: "0001840233"
company_name: "Xilio Therapeutics, Inc."
filed_at: "2026-03-09T23:59:59+00:00"
generated_at: "2026-05-15T18:08:40.586520+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Xilio Therapeutics posts corporate investor presentation; no new data in filing excerpt

## Summary
- Slide deck titled 'Unlocking the Potential of Immuno-Oncology Therapies' dated March 9, 2026.
- Presentation made available on company's website; no specific pipeline or financial details provided in this extract.
- Regulatory filing solely covers Reg FD disclosure of routine investor materials.

## SEC filing metadata
- accession: 0001193125-26-097603
- form_type: 8-K
- ticker: XLO
- cik: 0001840233
- company_name: Xilio Therapeutics, Inc.
- filed_at: 2026-03-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840233/000119312526097603/0001193125-26-097603-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840233/000119312526097603/xlo-20260309.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-097603
- JSON: https://secwatch.observer/filing/0001193125-26-097603.json
- Plain text: https://secwatch.observer/filing/0001193125-26-097603.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.